ISK Animal Health develops animal-health medicines, including BRENDA™, a treatment for reducing clinical signs associated with acute pancreatitis in dogs. Its fuzapladib sodium hydrate works through a distinct mechanism that blocks inflammatory-cell adhesion, and the product received manufacturing and marketing approval in Japan in 2018.